约 50 个结果
在新选项卡中打开链接
  1. Generic Drugs: Questions & Answers | FDA

    Generic Drug Facts At-a-glance information on generic medicines, including why they may look different or cost less than brand-name medicines.

  2. Overview & Basics | FDA

    2025年9月16日 · The FDA Office of Generic Drugs follows a rigorous review process to make sure that, compared to the brand-name (or innovator) medications, the proposed generic medications: Contain …

  3. FDA List of Authorized Generic Drugs

    2026年1月8日 · The FDA List of Authorized Generics page answers what an authorized generic is and how it differs from a traditional generic. An authorized generic is used to describe an approved brand …

  4. Generic Drugs | FDA

    2025年3月13日 · Understanding generic drugs. Consumer-friendly information on the safe and effective use of generic drugs.

  5. Generic Drug Facts | FDA

    Patents and exclusivities can affect when and how a generic drug can be marketed New brand-name drugs are usually protected by patents that prohibit others from selling generics of the same drug.

  6. This list of authorized generic drugs (AGs) was created from a manual review of FDA’s database of annual reports submitted to the FDA since January 1, 1999 by sponsors of new drug applications ...

  7. Generic drugs go through a rigorous review process to receive FDA approval. The FDA ensures a generic medication provides the same clinical benefit and is as safe and efective as the brand-name ...

  8. Office of Generic Drugs 2022 Annual Report | FDA

    In 2022, generic drugs remained a significant public health priority for the FDA. Competition from generic drug makers helped make drugs more widely available and generally less expensive ...

  9. First Generic Drug Approvals | FDA

    2025年10月23日 · FDA considers first generics to be important to public health, and prioritizes review of these submissions.

  10. Complex Generics News | FDA

    2024年11月22日 · Generics of complex brand name drugs (i.e., reference listed drugs) can be more difficult to develop. As such, a complex drug may be less likely to have an available generic.